Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids
Madelyn Arzt1,2,3,4, Stephany Pohlman1,2,3,4,5, Maedeh Mozneb1,2,3,4
1Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California.
This study details protocols for creating human induced pluripotent stem cell-derived cardiac spheroids. These 3D models enable advanced cardiac physiology studies and drug toxicity screening.
Area of Science:
- Stem Cell Biology
- Cardiovascular Research
- Biotechnology
Background:
- Human induced pluripotent stem cells (hiPSCs) can be differentiated into various cell types.
- Three-dimensional (3D) cardiac spheroids offer a more physiologically relevant model than 2D cultures.
- Existing models lack the complexity of native cardiac tissue, limiting their predictive power.
Purpose of the Study:
- To provide detailed protocols for generating hiPSC-derived cardiac spheroids.
- To enable the creation of multicellular cardiac models for research and drug screening.
- To facilitate patient-specific cardiac modeling.
Main Methods:
- Small-molecule-mediated differentiation of hiPSCs into cardiomyocytes, endothelial cells, and cardiac fibroblasts.
- Assembly of these differentiated cells into integrated cardiac spheroids using chemically defined medium.
- Protocols cover hiPSC maintenance, expansion, and directed differentiation.
Main Results:
- Established methods for differentiating hiPSCs into three key cardiac cell types.
- Successfully assembled hiPSC-derived cardiac spheroids incorporating cardiomyocytes, endothelial cells, and fibroblasts.
- Demonstrated a tri-cellular system for studying cell-cell interactions.
Conclusions:
- The developed protocols enable the generation of advanced 3D hiPSC-cardiac spheroids.
- These spheroids serve as valuable tools for cardiac physiology research and drug development.
- The methodology supports the creation of patient-specific cardiac models for personalized medicine.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
09:23Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023
